TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Infectious Disease
Division of General Internal Medicine
National Taiwan University Hospital Yunlin Branch
Division of General Internal Medicine
更新時間：2023-09-19
洪健清HUNG, CHIEN-CHING
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
85Publications
51
Liu CH, Huang YJ, Yang SS, Chang CH, Yang SS, Sun HY, Liu CJ, Liu WC, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Hung CC, Kao JH. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Sci Rep. 2018 Sep 12;8(1):13699. doi: 10.1038/s41598-018-32060-7. PMID: 30209349; PMCID: PMC6135833.
52
Lin KY, Hsieh SM, Sun HY, Lo YC, Sheng WH, Chuang YC, Cheng A, Pan SC, Chen GJ, Hung CC, Chang SC. Serologic responses and effectiveness of hepatitis A vaccination among human immunodeficiency virus-positive individuals during the outbreak of acute hepatitis A. Hepatology. 2018 Jul;68(1):22-31. doi: 10.1002/hep.29780. Epub 2018 May 9. PMID: 29328508.
53
Chen GJ, Lin KY, Sun HY, Sheng WH, Hsieh SM, Huang YC, Cheng A, Liu WC, Hung CC, Chang SC. Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: Impact of HAV vaccination. Liver Int. 2018 Apr;38(4):594-601. doi: 10.1111/liv.13468. Epub 2017 Jun 1. PMID: 28482131.
54
Sun HY, Chang SY, Hung CC. Dolutegravir-rilpivirine coformulation. Curr Opin HIV AIDS. 2018 Jul;13(4):320-325. doi: 10.1097/COH.0000000000000466. PMID: 29553948.
55
Lee YL, Chen GJ, Chen NY, Liou BH, Wang NC, Lee YT, Yang CJ, Huang YS, Tang HJ, Huang SS, Lin YC, Cheng CY, Lee CH, Chen TC, Wu TS, Liu CE, Lu PL, Hung CC; Taiwan HIV Study Group. Less Severe but Prolonged Course of Acute Hepatitis A in Human Immunodeficiency Virus (HIV)-Infected Patients Compared With HIV-Uninfected Patients During an Outbreak: A Multicenter Observational Study. Clin Infect Dis. 2018 Oct 30;67(10):1595-1602. doi: 10.1093/cid/ciy328. PMID: 29672699.
56
Liu CH, Sun HY, Liu CJ, Sheng WH, Hsieh SM, Lo YC, Liu WC, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Hung CC, Kao JH. Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection. Aliment Pharmacol Ther. 2018 Jun;47(12):1690-1698. doi: 10.1111/apt.14647. Epub 2018 Apr 17. PMID: 29665069.
57
Li CW, Yang CJ, Sun HY, Tsai MS, Lin SP, Lin TY, Cheng CY, Lee YC, Huang YS, Liu CE, Lee YT, Tang HJ, Wang NC, Cheng SH, Ko WC, Hung CC; Taiwan HIV Study Group. Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. PLoS One. 2018 Mar 16;13(3):e0194149. doi: 10.1371/journal.pone.0194149. PMID: 29547628; PMCID: PMC5856341.
58
Llibre JM, Hung CC, Brinson C, Castelli F, Girard PM, Kahl LP, Blair EA, Angelis K, Wynne B, Vandermeulen K, Underwood M, Smith K, Gartland M, Aboud M. Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies. Lancet. 2018 Mar 3;391(10123):839-849. doi: 10.1016/S0140-6736(17)33095-7. Epub 2018 Jan 6. Erratum in: Lancet. 2018 Feb 1;: PMID: 29310899.
59
Chen GJ, Sun HY, Lin KY, Cheng A, Huang YC, Hsieh SM, Sheng WH, Liu WC, Hung CC, Chang SC. Serological responses to revaccination with hepatitis A virus (HAV) vaccines among HIV-positive individuals whose anti-HAV antibody waned after primary vaccination. Liver Int. 2018 Jul;38(7):1198-1205. doi: 10.1111/liv.13665. Epub 2018 Jan 8. PMID: 29240985.
60
Boucher CA, Bobkova MR, Hung CC, Kaiser R, Marcelin AG, Streinu-Cercel A, van Wyk J, Dorr P, Vandamme AM. State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps. AIDS Rev. 2018 Jan-Mar;20(1):43-57. PMID: 29628514.
